Predicate |
Object |
contentType |
Journal Article|Comment |
endingPage |
284 |
issn |
1759-4774 1759-4782 |
issueIdentifier |
5 |
pageRange |
284-284 |
publicationName |
Nature reviews. Clinical oncology |
startingPage |
284 |
bibliographicCitation |
Sidaway P. Nirogacestat effective in desmoid tumours. Nat Rev Clin Oncol. 2023 May;20(5):284. doi: 10.1038/s41571-023-00758-x. PMID: 36997640. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da27973c94fb7ae7fad66dd5c3c8c7f9 |
date |
2023-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1038/s41571-023-00758-x https://pubmed.ncbi.nlm.nih.gov/36997640 |
isPartOf |
https://portal.issn.org/resource/ISSN/1759-4782 https://portal.issn.org/resource/ISSN/1759-4774 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35768 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Nirogacestat effective in desmoid tumours |
discusses |
http://id.nlm.nih.gov/mesh/M000734587 http://id.nlm.nih.gov/mesh/M0022497 http://id.nlm.nih.gov/mesh/M0021234 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10143 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46224413 |